Posizioni attive di Stephen Goodall
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| FIREBRICK PHARMA LIMITED | Direttore/Membro del Consiglio | 12/04/2012 | - |
| Direttore operativo | 12/04/2012 | - | |
| Fondatore | 12/04/2012 | - |
Storia della carriera di Stephen Goodall
Precedenti posizioni note di Stephen Goodall
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| VIRALYTICS LTD. | Direttore operativo | 25/10/2009 | 31/08/2011 |
Vapotronics, Inc.
 Vapotronics, Inc. Medical SpecialtiesHealth Technology Vapotronics, Inc. develops inhalation drug products. The company is headquartered in South Brisbane, Australia. | Corporate Officer/Principal | 01/08/1999 | 01/06/2001 |
Statistiche
Distribuzione geografica
| Australia | 4 |
Posizioni
| Chief Operating Officer | 2 |
| Director/Board Member | 1 |
| Founder | 1 |
Settori
| Health Technology | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| FIREBRICK PHARMA LIMITED | Health Technology |
| Aziende private | 2 |
|---|---|
Viralytics Pty Ltd.
 Viralytics Pty Ltd. BiotechnologyHealth Technology Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia. | Health Technology |
Vapotronics, Inc.
Vapotronics, Inc. Medical SpecialtiesHealth Technology Vapotronics, Inc. develops inhalation drug products. The company is headquartered in South Brisbane, Australia. | Health Technology |
- Borsa valori
- Insiders
- Stephen Goodall
- Esperienza
